T. Rowe Price Associates
VIVO

T. Rowe Price Associates’s Meridian Bioscience Inc VIVO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-27,215
Closed -$904K 3003
2022
Q4
$904K Sell
27,215
-800
-3% -$26.6K ﹤0.01% 1821
2022
Q3
$884K Buy
28,015
+1,336
+5% +$42.2K ﹤0.01% 1817
2022
Q2
$812K Sell
26,679
-8,931
-25% -$272K ﹤0.01% 1982
2022
Q1
$924K Buy
35,610
+2,302
+7% +$59.7K ﹤0.01% 2042
2021
Q4
$679K Sell
33,308
-2,600
-7% -$53K ﹤0.01% 2234
2021
Q3
$691K Hold
35,908
﹤0.01% 2220
2021
Q2
$796K Buy
35,908
+793
+2% +$17.6K ﹤0.01% 2159
2021
Q1
$922K Buy
35,115
+2,693
+8% +$70.7K ﹤0.01% 2091
2020
Q4
$606K Buy
32,422
+390
+1% +$7.29K ﹤0.01% 2169
2020
Q3
$544K Buy
32,032
+14,100
+79% +$239K ﹤0.01% 2058
2020
Q2
$418K Buy
17,932
+195
+1% +$4.55K ﹤0.01% 2122
2020
Q1
$149K Buy
17,737
+210
+1% +$1.76K ﹤0.01% 2364
2019
Q4
$171K Buy
17,527
+1,669
+11% +$16.3K ﹤0.01% 2413
2019
Q3
$150K Buy
15,858
+191
+1% +$1.81K ﹤0.01% 2407
2019
Q2
$186K Buy
15,667
+131
+0.8% +$1.56K ﹤0.01% 2409
2019
Q1
$274K Buy
15,536
+100
+0.6% +$1.76K ﹤0.01% 2317
2018
Q4
$268K Buy
+15,436
New +$268K ﹤0.01% 2324
2018
Q1
Sell
-11,491
Closed -$161K 2572
2017
Q4
$161K Buy
+11,491
New +$161K ﹤0.01% 2437
2017
Q1
Sell
-1,004,555
Closed -$17.8M 2602
2016
Q4
$17.8M Sell
1,004,555
-1,488,480
-60% -$26.3M ﹤0.01% 1174
2016
Q3
$48.1M Sell
2,493,035
-33,460
-1% -$645K 0.01% 817
2016
Q2
$49.3M Sell
2,526,495
-18,080
-0.7% -$353K 0.01% 788
2016
Q1
$52.4M Sell
2,544,575
-38,580
-1% -$795K 0.01% 757
2015
Q4
$53M Buy
2,583,155
+47,070
+2% +$966K 0.01% 746
2015
Q3
$43.4M Sell
2,536,085
-30,460
-1% -$521K 0.01% 815
2015
Q2
$47.8M Sell
2,566,545
-4,900
-0.2% -$91.3K 0.01% 854
2015
Q1
$49.1M Sell
2,571,445
-100,560
-4% -$1.92M 0.01% 851
2014
Q4
$44M Buy
2,672,005
+43,100
+2% +$709K 0.01% 886
2014
Q3
$46.5M Buy
2,628,905
+71,600
+3% +$1.27M 0.01% 856
2014
Q2
$52.8M Sell
2,557,305
-75,030
-3% -$1.55M 0.01% 850
2014
Q1
$57.4M Sell
2,632,335
-5,650
-0.2% -$123K 0.01% 815
2013
Q4
$70M Sell
2,637,985
-420,360
-14% -$11.2M 0.02% 718
2013
Q3
$72.3M Buy
3,058,345
+7,470
+0.2% +$177K 0.02% 682
2013
Q2
$65.6M Buy
+3,050,875
New +$65.6M 0.02% 694